Integrated Biobehavioral Treatment of Migraine- A Focus on Children, Adolescents, and Young Adults (Archived)

Migraine is the second most disabling disease in the world, yet it is underdiagnosed, under-recognized, and undertreated. Migraine most often begins in adolescence or young adulthood, affecting over 10% of the population, and continues as a chronic illness throughout the majority of life. Based on evidence from Phase 3 clinical trials with adults and youth, a combination of behavioral therapy with a pill-based prevention strategy is optimal care in terms of reducing headache days and related disability. This webinar will take a pediatric viewpoint to discuss this field and will highlight treatments that work and current efforts to understand brain and pain processing mechanisms that may drive the success of biobehavioral therapies